Table 2

Effects of treatment with low doses of RG7112 and Peg-IFNα 2a alone or in combination on the number of WT JAK2 hematopoietic colonies

Patient number*JAK2 V617F allele burden (%)Total of colonies genotyped% Of hematopoietic colonies with WT JAK2
Cytokines only (control)Peg-IFNα 2aRG7112RG7112 + IFNα
14 127 58 56.5 46 70.6 
15 70 129 14.3 26.1 23 40* 
49 144 70 67 71 79 
22 132 38 47 45 50 
13 75 180 21 32 25 50 
14 20 168 31 44 28 45 
40 189 79 83 79 87 
16 50 121 24 
22 70 121 27 
21 45 112 50 80 58.3 83.3 
19 105 12.5 20 64 90.9 
Patient number*JAK2 V617F allele burden (%)Total of colonies genotyped% Of hematopoietic colonies with WT JAK2
Cytokines only (control)Peg-IFNα 2aRG7112RG7112 + IFNα
14 127 58 56.5 46 70.6 
15 70 129 14.3 26.1 23 40* 
49 144 70 67 71 79 
22 132 38 47 45 50 
13 75 180 21 32 25 50 
14 20 168 31 44 28 45 
40 189 79 83 79 87 
16 50 121 24 
22 70 121 27 
21 45 112 50 80 58.3 83.3 
19 105 12.5 20 64 90.9 

24 to 48 colonies were plucked and examined in each condition.

*

Patient numbers are listed in supplemental Table 2.

Benefits of the combination therapy are defined as the appearance of at least a 10% greater increase in WT colonies after combination therapy compared with the colonies treated with a single agent.

or Create an Account

Close Modal
Close Modal